Cite
HARVARD Citation
Sakamoto, K. et al. (2020). A Phase 1, Randomized, Placebo‐Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Subcutaneous Tezepelumab in Healthy Japanese Men. Clinical pharmacology in drug development. 9 (7), pp. 833-840. [Online].